Michael Calabrese Comments on Wall Street’s Challenge to New SEC Private Fund Adviser Rule
September 1, 2023
The Hill
Âé¶¹Ö±²¥ & Lardner LLP partner Michael Calabrese is quoted in The Hill article, “,â€� discussing a recent lawsuit filed by a cohort of trade associations challenging the SEC’s new Private Fund Adviser rule.
“The failure to include standard of care language in the final rule really leaves investors with no greater protection than if the new rules had not been adopted,� Calabrese explained. “In some ways, this runs counter to one of the principles that seemed to underlie the Commission’s efforts – discouraging preferential treatment.�
“Larger investors, and those with statutory or policy mandates on this issue, will continue to get better results here than others,� Calabrese added.
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Âé¶¹Ö±²¥
Âé¶¹Ö±²¥ & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Âé¶¹Ö±²¥ & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,â€� examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Âé¶¹Ö±²¥ & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.